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Diabetes
While early diagnosis and treatment leads to
improved outcomes, diabetes remains undi-
agnosed in up to 50% of patients.3-5
In the remote Kimberley region of Western
Australia, guidelines for the diagnosis of dia-
betes, based on national Australian guide-
lines,6,7 require two separate laboratory
corre
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Objectives:  To determine the utility of point-of-care (POC) capillary blood glucose 
measurements in the diagnosis and exclusion of diabetes in usual practice in primary 
health care in remote areas.
Design:  Cross-sectional study comparing POC capillary glucose results with 
sponding venous glucose levels measured in a reference laboratory.
cipants:  200 participants aged 16–65 years enrolled: 198 had POC capillary 
se measurements; 164 also had acceptable venous glucose laboratory results.
ng:  Seven health care sites in the Kimberley region of Western Australia from 
to November 2006.
 outcome measures:  Concordance and mean differences between POC capillary 
d glucose measurement and laboratory measurement of venous blood glucose 
level; POC capillary blood glucose equivalence values for excluding and diagnosing 
diabetes, and their sensitivity, specificity and positive-predictive value.
Results:  The concordance between POC and laboratory results was high (ρ = 0.93, 
P < 0.001). The mean difference in results was 0.48 mmol/L (95% CI, 0.23–0.73; limits 
of agreement, −2.6 to 3.6 mmol/L). The POC capillary glucose equivalence values for 
excluding and diagnosing diabetes were < 5.5 mmol/L (sensitivity, 53.3%; specificity, 
94.4%; positive-predictive value, 88.9%; for a venous value of < 5.5 mmol/L) and 
 12.2 mmol/L (sensitivity, 83.3%; specificity, 99.3%; positive-predictive value, 95.2%; 
for a venous value of  11.1 mmol/L), respectively. While the choice of glucometer and 
whether or not patients were fasting altered these results, they did not have a significant 
influence on the diagnostic utility of POC glucose measurement in this setting.
Conclusion:  POC capillary blood glucose analysers can be used as part of the process 
of diagnosing and excluding diabetes in remote rural communities using these locally 
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established capillary equivalence values.iab
tio
facD etes and its associated complica-ns are a significant health probleming Indigenous Australians. The
prevalence of type 2 diabetes mellitus in
Aboriginal and Torres Strait Islander peoples
has been estimated to be as high as 32%.1,2
venous blood glucose measurements show-
ing raised levels in an asymptomatic patient,
one elevated venous blood glucose measure-
ment in a symptomatic patient, or an oral
glucose tolerance test consistent with diabe-
tes.8 Due to the distance of many health care
clinics from a laboratory, and the infrequent
transport links, the requirement for venous
glucose results can significantly delay diagno-
sis, patient feedback and education. Many
people also move between communities and
venous glucose results may not be readily
available when the person is next seen.
Immediate results with diagnostic signifi-
cance would improve the diagnosis and man-
agement of diabetes at remote sites. While
earlier studies have shown a high level of
concordance between laboratory venous
blood glucose and point-of-care (POC) capil-
lary blood glucose measurements, these have
mainly been conducted in controlled, urban
environments.9-11 In 2003, Martin et al,2 at a
single remote clinic in the Kimberley, showed
that POC capillary glucose measurement may
be useful as a screening tool to exclude a
diagnosis of diabetes. However, this study
used well calibrated and maintained equip-
ment operated by specifically trained staff,
and thus did not reflect “real world” remote
health care.
We aimed to determine whether POC cap-
illary blood glucose measurement was suffi-
ciently accurate to allow the diagnosis or
exclusion of diabetes as part of usual remote
primary health care practice.
METHODS
Data were collected by local health care pro-
viders from May to November 2006 at seven
sites across the Kimberley (Box 1). Any
patient who had venous blood glucose meas-
urement requested as part of usual clinical
care was invited to participate.
POC glucose measurement 
and venipuncture
POC measurement of capillary blood glucose
and venipuncture were done concurrently
and the time of each test was recorded. Data
were excluded if POC capillary glucose meas-
urement and venipuncture occurred more
than 30 minutes apart.
Capillary blood glucose was measured by a
primary health care provider via a finger-
prick blood sample and analysed on the POC
glucometer usually used at each site. No
attempt was made to standardise health-pro-
vider education, or glucometer maintenance
or calibration. The two glucometers used in
our study were the Accu-Chek Advantage
(Roche Diagnostics, Sydney, NSW), which
displays whole blood capillary glucose levels,
and the MediSense Optium (Abbott Diabetes
Care, Melbourne, Vic), which mathematically
converts a whole blood measurement to a
capillary plasma glucose level (technical data
supplied by the manufacturer).
Venous whole blood samples were col-
lected in containers with fluoride oxalate.
Normal procedures at each clinic were used
for storage (whole blood was stored at 4°C)
and transport of whole blood samples to one
of the three laboratories in the Kimberley
region (Box 1).
Venous plasma glucose levels were meas-
ured enzymatically on a Vitros 250 Analyser
(Ortho-Clinical Diagnostics, Rochester, NY,
USA) using glucose oxidase spectrophoto-
metric dry chemistry. The distance to the
laboratory from the study sites ranged from
2 km by road to 280 km by air, and the timeMJA • Volume 186 Number 10 • 21 May 2007
DIABETESfor the specimen to reach the laboratory
varied from 30 min to 7 days.
Ethical approval
Ethical approval was obtained from The Uni-
versity of Western Australia Human Research
Ethics Committee and the Western Austra-
lian Aboriginal Health Information and Eth-
ics Committee. All study participants were
provided with verbal and written information
regarding the study, and informed written
consent was obtained. If necessary, Aborigi-
nal health workers provided cultural and
language translations.
Statistical analysis
Data were analysed using SPSS, version 14.0
(SPSS Inc, Chicago, Ill, USA) and Stata,
version 7.0 (StataCorp, College Station, Tex,
USA) and are presented as mean and 95%
confidence intervals (CIs) unless otherwise
stated. Concordance between POC and lab-
oratory blood glucose values was assessed
by the technique of Lin,12 which measures
the agreement between two methods. Mean
difference (bias) and limits of agreement
were determined using the techniques of
Bland and Altman.13 POC capillary equiva-
lence values for excluding and diagnosing
diabetes were determined from receiver
operating characteristics (ROC) curves,
using laboratory values of < 5.5 and
 11.1 mmol/L, respectively. Differences in
proportions were determined using the two-
tailed Fisher’s exact test. Multivariate linear
regression analysis was used to determine
whether patient or processing factors
affected the relationship between POC and
laboratory glucose levels.
2 Comparison of subjects included and excluded from the analysis
Included (n = 164) Excluded (n = 36)
Median age (range) in years 44 (16–65) 47 (14–86)
Women (%) 99 (60%) 27 (75%)
Aboriginal and/or Torres Strait Islander (%) 150 (91%) 31 (86%)
Pre-existing diagnosis of diabetes (%) 68 (41%) 23 (64%)
Fasting at time of glucose measurement (%) 36 (22%) 7 (19%)
Accu-Chek glucometer used (%) 35 (21%) 18 (50%)
3 Concordance analysis of point-of-care (POC) and laboratory glucose results
A: All unadjusted readings (plasma and whole blood levels) (n = 164); B: Capillary plasma 
MediSense readings converted to whole-blood levels (n = 129); C: Unadjusted Accu-Chek 
readings (whole blood levels) (n = 35). Dashed line in A, B and C = line of perfect concordance. 
D: Difference plot (Bland–Altman analysis13) for all POC versus laboratory blood glucose 
measurements (n = 164). Dashed line in D = 95% limits of agreement. ◆
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 = 0.93; SE, 0.01; P < 0.001  = 0.90; SE, 0.01; P < 0.001
 = 0.91; SE, 0.03; P < 0.001
1 Health care sites where the study 
was conducted, the Kimberley, 
Western Australia*
* The Kimberley region extends 1100 km from east 
to west and 850 km from north to south. Study 
sites included community-controlled Aboriginal 
health services in Broome and Derby, the 
Kimberley regional dialysis centre in Broome, and 
four primary health care centres in remote 
Aboriginal communities. ◆
Broome
Derby
Kalumburu
Oombulgurri
Kununurra
Bidyadanga
Lombadina-
Djarindjin
Pathology laboratories        
Indicates the only sealed road 
traversing the KimberleyMJA • Volume 186 Number 10 • 21 May 2007 501
DIABETESRESULTS
Two hundred participants were enrolled, and
164 included in the analysis. The reasons for
exclusion were missing or inadequate tests in
29 participants, and more than 30 minutes
elapsing between POC measurement and
venipuncture in seven participants. Descrip-
tive data on participants are listed in Box 2.
Almost half of the excluded subjects (44%)
were assessed at one clinic, which happened
to use an Accu-Chek glucometer, reducing
the number of results for that glucometer.
Unadjusted POC blood glucose measure-
ments and laboratory-measured venous
blood glucose levels showed a high degree
of concordance (Box 3A). The concordance
was only marginally altered by stratifying
the analysis by different glucometers and
back-converting the MediSense POC results
from plasma to whole blood (Box 3B and
Box 3C). The limits of agreement between
POC and laboratory values are presented in
Box 3D. Fasting POC blood specimens
tended to have greater concordance with
laboratory values (ρ = 0.96; SE, 0.01;
P < 0.001) compared with non-fasting speci-
mens (ρ = 0.92; SE, 0.01; P < 0.001).
In a multivariate analysis, the MediSense
glucometer and fasting at the time of blood
glucose measurement were associated with
less difference between the POC and labora-
tory glucose levels at clinically important val-
ues (0–12 mmol/L) and greater differences at
higher values. These associations did not alter
the explained variance of the model (r2=
0.89), suggesting that this statistical relation-
ship was of no clinical significance. The rela-
tionship between POC and laboratory glucose
levels was not independently influenced by
the time between POC glucose measurement
and venipuncture, a pre-existing diagnosis of
diabetes, or the time delay in collecting and
processing the laboratory specimen.
The most clinically appropriate POC
threshold value for excluding (venous blood
glucose level, <5.5 mmol/L) or diagnosing
diabetes (venous blood glucose level,
 11.1 mmol/L) was determined using ROC
curves (Box 4). A POC reading of <5.5mmol/L
had a sensitivity of 53.3%, a specificity of
94.4%, and a positive-predictive value of
88.9% for a venous value of < 5.5 mmol/L.
Sensitivity was increased to 61.9% (Fisher’s
exact test, P=0.44) in those subjects who had
fasted before blood glucose measurement.
The choice of POC glucometer had a signifi-
cant influence on sensitivity (Accu-Chek,
29.4%; MediSense, 60.3%; P<0.05). How-
ever, none of these factors greatly influenced
specificity. POC readings  12.2mmol/L had
5 Recommendations for the use of point-of-care glucose measurement in 
screening for and diagnosing diabetes in adults in the Kimberley
STDs = sexually transmitted diseases. ◆
Prompt annual screening for diabetes in all 
Kimberley residents aged 15 years and over
Laboratory testing of levels of glucose, 
lipids, glycated haemoglobin,
and estimated glomerular filtration rate
Point-of-care capillary blood glucose testing
Venous blood required for other reasons 
(eg, lipids testing due, serological screening for STDs)
Laboratory testing of venous blood glucose level
Further management based on the laboratory venous blood glucose level and the diabetes type 2
management protocol of the Kimberley Regional Guidelines8 
Yes No
5.5–12.1 mmol/L< 5.5 mmol/L  12.2 mmol/L
Diabetes unlikely
Retest in 1 year
Diabetes likely
4 Receiver operating characteristics (ROC) curves for excluding and diagnosing 
diabetes
A: ROC curves for excluding diabetes (laboratory-measured glucose level,< 5.5 mmol/L). 
B: ROC curves for diagnosing diabetes (laboratory-measured glucose level, 11.1 mmol/L). ◆
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DIABETESa sensitivity of 83.3%, a specificity of 99.3%,
and a positive-predictive value of 95.2% for a
venous value of  11.1 mmol/L. In this set-
ting, sensitivity was non-significantly reduced
in fasted subjects (75.0%; P=0.54) and when
using the MediSense glucometer (81.3%; P=
1.0) compared with not fasted (85.0%) and
using the Accu-Chek glucometer (87.5%).
Again, specificity was not greatly influenced
by these factors.
DISCUSSION
Our study confirmed that obtaining venous
glucose results in a timely manner in remote
areas is very difficult. Some samples took 7
days to reach the laboratory, and on many
occasions an appropriate venous sample did
not arrive at all, leading to further delays and/
or missed diagnoses. Thus, for logistical rea-
sons, relying solely on venous laboratory
results remains a significant problem in the
Kimberley and other remote areas.
POC values were generally marginally
higher than venous samples at the lower end
of the scale, but lower than venous results at
the upper end of the scale (Box 3D). Never-
theless, this difference did not alter the diag-
nostic utility of POC capillary blood glucose
measurement in this setting, as its high spe-
cificity showed. We also found that fasting
POC blood glucose results are more sensitive
than non-fasting results in excluding diabe-
tes, and less sensitive in diagnosing it. How-
ever, it was reassuring that, regardless of
whether the test was performed fasting or
non-fasting, and irrespective of the glucome-
ter used, specificity at both ends of the
diagnostic range remained high.
In clinical practice, being able to either
diagnose or exclude diabetes is far more
important than concordance between POC
and venous plasma levels across the range of
glucose levels. The cut-off values for POC
glucose levels and their diagnostic utility,
however, require validation.10 While the
guidelines of the Central Australian Rural
Practitioners Association (CARPA) use cut-
offs of 5.0 and 12.0 mmol/L,14 these are not
evidence-based. Our results concurred with
the World Health Organization recommenda-
tions of random POC plasma glucose levels
 12.2 mmol/L for diagnosing diabetes and
< 5.5 mmol/L for excluding diabetes.15
Assuming that the study population was typ-
ical of Kimberley residents undergoing
screening for diabetes, using a POC glucose
cut-off of 5.5 mmol/L to exclude diabetes will
reduce the need for venipuncture by 24%.
The national Australian guidelines for dia-
betes management recommend against using
POC glucometers on the basis that they are
not sufficiently accurate.6,7 Our study shows
that, in real-world remote settings, POC
measurement of blood glucose, with appro-
priate use of laboratory glucose measure-
ment, is sufficiently accurate to be an
important component of diabetes screening.
In remote areas of Australia, POC glucose
measurement can expedite the diagnosis of
diabetes in high-risk, remote-dwelling popu-
lations and provide opportunities for imme-
diate education and initiation of treatment.
Recommendations for the use of POC glu-
cose measurement in the Kimberley devel-
oped from our study are outlined in Box 5.
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